Journal
JOURNAL OF IMMUNOLOGY
Volume 175, Issue 12, Pages 7800-7804Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.175.12.7800
Keywords
-
Categories
Funding
- NCI NIH HHS [T32CA09054] Funding Source: Medline
- NIAID NIH HHS [AI050606] Funding Source: Medline
- NIGMS NIH HHS [T32GM007311] Funding Source: Medline
Ask authors/readers for more resources
Recently, it has been demonstrated that stimulated T cells bearing defects in caspase-8 fail to promote nuclear shuttling of NF-kappa B complexes. Such cells display strikingly similar proliferative and survival defects as T cells lacking Fas-associated death domain protein (FADD) function. We characterized NF-kappa B signaling in T cells bearing a dominant-negative FADD transgene (FADDdd). Whereas FADDdd T cells displayed proliferative defects following activation, these were not a consequence of aberrant NF-kappa B signaling, as measured by IKK/I kappa B phosphorylation and I kappa B degradation. There were no appreciable defects in nuclear translocation of p65/Rel using ImageStream, a flow-based imaging cytometer. Pretreatment with benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone, a potent caspase inhibitor, also failed to impede canonical NF-kappa B signaling. Secretion of IL-2 and up-regulation of various activation markers occurred normally. Thus, FADD does not play an essential role in NF-kappa B activation, suggesting an alternative route by which this adaptor promotes the clonal expansion of T cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available